Skip to main content
Explore URMC
menu

Patrick M. Reagan, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Fax: (585) 273-5761

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting

Cancer

Biography

I am a clinician and researcher specializing in the care of patients with both Non Hodgkin and Hodgkin lymphomas. Areas of particular interest include aggressive B-cell lymphomas such as diffuse large B-cell lymphoma and "double hit" lymphoma, autologous stem cell transplantation and cellular therapy including chimeric antigen receptor (CAR) T-cells.

Lymphomas are a complex group of diseases and require a multidisciplinary team to manage. We are fortunate to have an excellent team at the Wilmot Cancer Institute including hematology and oncology, radiation oncology, hematopathology, dermatology, neurology, nursing, advanced practice providers, social work and members of the clinical trials office.

I am actively engaged in clinical trials research and feel that this is an important component of care for lymphoma patients.

My lymphoma practice team includes Taylor Fox, NP and Abir Hines, RN. My team for autologous stem cell transplantation and CAR T-cells includes Anna Morrison, RN.

Professional Background

Dr. Reagan is an Assistant Professor of Medicine at the Wilmot Cancer Institute.

Dr. Reagan received his medical degree from Upstate Medical University in Syracuse, NY. He completed his internship and residency at the University of Virginia. He then served as a chief resident at the University of Virginia. He completed his fellowship in hematology at the Wilmot Cancer Institute at the University of Rochester Medical Center.

He started his faculty appointment at the Wilmot Cancer Institute in July 2015.

Credentials

Specialties

  • Hematology - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine

Education

2005
BS | St. Lawrence University
Neuroscience

2009
MD | SUNY Upstate Medical University
Medicine

2009-2012
| University of Virginia
Resident

2012-2013
| University of Virginia
Chief Resident

2013-2015
| University of Rochester, Rochester, NY
Fellow in Hematology

Post-doctoral Training & Residency

07/01/2013 - 06/30/2015
Fellowship in Hematology/Oncology at University of Rochester Medical Center - GME Office

07/01/2012 - 07/01/2013
Residency in Internal Medicine at University of Virginia Children's Hospital

07/01/2010 - 07/01/2012
Residency in Internal Medicine at University of Virginia Children's Hospital

07/01/2009 - 7/1/2010
Internship in Internal Medicine at University of Virginia Children's Hospital

VIEW ALL expand_more

Awards

2018
Lymphoma Research Foundation Clinical Research Mentoring Program

2015
American Society of Hematology Clinical Research Training Institute

2014
John and Carol Bennett Travel Fellowship Award
Sponsor: John and Carol Bennett
Location: Wilmot Cancer Institute

2009
Alpha Omega Alpha, Upstate Medical University
Sponsor: Upstate Medical University

2005
Phi Beta Kappa, St. Lawrence University
Sponsor: St. Lawrence University

2004
Academic All American, Football, St. Lawrence University
Sponsor: St. Lawrence University


Beta Beta Beta, Biological Honor Society, St. Lawrence University
Sponsor: St. Lawrence University

VIEW ALL expand_more

Publications

Journal Articles

7/8/2019
Loh KP, Baran A, Lee CY, Alshaibani A, Rutherford SC, Hu J, Casulo C, Barr PM, Friedberg JW, Reagan PM. "Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation." Leukemia & lymphoma.. 2019 Jul 8; :1-4. Epub 2019 Jul 08.

5/28/2019
Tomlinson SB, Sandwell S, Chuang ST, Johnson MD, Vates GE, Reagan PM. "Central nervous system relapse of systemic ALK-rearranged anaplastic large cell lymphoma treated with alectinib." Leukemia research.. 2019 May 28; 83:106164. Epub 2019 May 28.

11/30/2018
"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial." The Lancet. Oncology.. 2018 Nov 30; Epub 2018 Nov 30.

VIEW ALL PUBLICATIONS